CVE-2026-113352 is a high-severity (CVSS 7.5) Path Traversal vulnerability. No vendor fix is recorded yet; mitigation options are listed below.
uTox through 0.18.1 contains a path traversal vulnerability that allows Tox friends to write arbitrary files by sending absolute or ../ file names to victims with auto-accept enabled.…
Exploitation Status
No confirmed exploitation observed yet
- A successful exploit gives an attacker total control of the affected component, not partial access.
- CISA’s own triage has not observed active exploitation or public proof-of-concept code for this CVE as of its last assessment.
Exploitation and automatability from CISA’s SSVC triage for CVE-2026-113352.
Description
uTox through 0.18.1 contains a path traversal vulnerability that allows Tox friends to write arbitrary files by sending absolute or ../ file names to victims with auto-accept enabled. Attackers can overwrite shell startup files or plant crafted .ftinfo resume records that ft_find_resumeable() loads, abusing FILE pointers to write /proc/self/mem and execute code.
Detection & mitigation playbook
VulnerabilityDetect
Identify every host running the affected component and compare the installed build against the fixed version below — for source-built or distro-packaged software the version string, not a lockfile, is the source of truth (`dpkg -l`, `rpm -q`, or the binary's own `--version`).
Remediation status
No fixed release is recorded for CVE-2026-113352 yet. Track the upstream advisory, and apply the exposure-reduction steps below in the meantime.
Mitigate without a patch
Resolve every user-supplied path to its canonical form and reject anything that escapes the intended directory, and run the component under an account that has no read or write access outside the directory it legitimately serves.
Frequently Asked Questions
Is CVE-2026-113352 in your dependencies?
Find it across , including transitive dependencies.